Anna Syreeni

888 total citations
15 papers, 172 citations indexed

About

Anna Syreeni is a scholar working on Surgery, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Anna Syreeni has authored 15 papers receiving a total of 172 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Genetics and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Anna Syreeni's work include Pancreatic function and diabetes (5 papers), Diabetes and associated disorders (4 papers) and Diabetes Treatment and Management (3 papers). Anna Syreeni is often cited by papers focused on Pancreatic function and diabetes (5 papers), Diabetes and associated disorders (4 papers) and Diabetes Treatment and Management (3 papers). Anna Syreeni collaborates with scholars based in Australia, Finland and United States. Anna Syreeni's co-authors include Per‐Henrik Groop, Carol Forsblom, Niina Sandholm, Alexander P. Maxwell, Amy Jayne McKnight, Maikki Parkkonen, Lise Tarnow, Mark E. Cooper, Hans‐Henrik Parving and Assam El‐Osta and has published in prestigious journals such as Diabetes, Scientific Reports and Diabetologia.

In The Last Decade

Anna Syreeni

14 papers receiving 170 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Syreeni Australia	8	63	57	48	45	29	15	172
Erdal Kurnaz Türkiye	10	62 1.0×	91 1.6×	38 0.8×	48 1.1×	40 1.4×	39	242
Joseph Coney United States	6	25 0.4×	22 0.4×	25 0.5×	64 1.4×	119 4.1×	18	211
M. Temel Yılmaz Türkiye	9	66 1.0×	58 1.0×	69 1.4×	94 2.1×	33 1.1×	29	247
Kim Lawson United States	7	80 1.3×	38 0.7×	114 2.4×	57 1.3×	22 0.8×	9	263
Tadasu Kasahara Japan	8	115 1.8×	61 1.1×	100 2.1×	155 3.4×	8 0.3×	22	259
Тамара Леонидовна Кураева Russia	10	135 2.1×	62 1.1×	102 2.1×	153 3.4×	7 0.2×	59	278
Dorota Raczyńska Poland	11	22 0.3×	63 1.1×	30 0.6×	23 0.5×	235 8.1×	20	364
Diego Bailetti Italy	10	37 0.6×	55 1.0×	54 1.1×	95 2.1×	2 0.1×	20	229
B Mirkiewicz-Sieradzka Poland	7	32 0.5×	53 0.9×	43 0.9×	51 1.1×	70 2.4×	17	232
Olga Mikhailovna Smirnova Russia	6	23 0.4×	27 0.5×	35 0.7×	67 1.5×	8 0.3×	39	137

Countries citing papers authored by Anna Syreeni

Since Specialization

Citations

This map shows the geographic impact of Anna Syreeni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Syreeni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Syreeni more than expected).

Fields of papers citing papers by Anna Syreeni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Syreeni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Syreeni. The network helps show where Anna Syreeni may publish in the future.

Co-authorship network of co-authors of Anna Syreeni

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Syreeni. A scholar is included among the top collaborators of Anna Syreeni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Syreeni. Anna Syreeni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Chen, Zhuo, Eiichiro Satake, Marcus G. Pezzolesi, et al.. (2024). Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes. Science Translational Medicine. 16(748). eadj3385–eadj3385. 8 indexed citations

Haukka, Jani K., Erkka Valo, Anna Syreeni, et al.. (2024). Whole-exome and whole-genome sequencing of 1064 individuals with type 1 diabetes reveals novel genes for diabetic kidney disease. Diabetologia. 67(11). 2494–2506.

Haukka, Jani K., Anmol Kumar, Anna Syreeni, et al.. (2024). Whole-genome sequencing identifies variants in ANK1, LRRN1, HAS1, and other genes and regulatory regions for stroke in type 1 diabetes. Scientific Reports. 14(1). 13453–13453. 1 indexed citations

Haukka, Jani K., Valma Harjutsalo, Nina Mars, et al.. (2023). Residual insulin secretion in individuals with type 1 diabetes in Finland: longitudinal and cross-sectional analyses. The Lancet Diabetes & Endocrinology. 11(7). 465–473. 16 indexed citations

Syreeni, Anna, Luke Carroll, Stefan Mutter, et al.. (2022). Telomeres do not always shorten over time in individuals with type 1 diabetes. Diabetes Research and Clinical Practice. 188. 109926–109926. 5 indexed citations

Sandholm, Niina, Jani K. Haukka, Emma H. Dahlström, et al.. (2022). Whole-exome sequencing identifies novel protein-altering variants associated with serum apolipoprotein and lipid concentrations. Genome Medicine. 14(1). 132–132. 7 indexed citations

Syreeni, Anna, Emma H. Dahlström, Carol Forsblom, et al.. (2022). Haptoglobin Genotype Does Not Confer a Risk of Stroke in Type 1 Diabetes. Diabetes. 71(12). 2728–2738. 1 indexed citations

Jenkins, Alicia J., Anna Syreeni, Stefan Mutter, Andrzej S. Januszewski, & Per‐Henrik Groop. (2022). Telomeres in clinical diabetes research – Moving towards precision medicine in diabetes care?. Diabetes Research and Clinical Practice. 194. 110178–110178. 4 indexed citations

Sandholm, Niina, David‐Alexandre Trégouët, Amy Jayne McKnight, et al.. (2020). Genome-wide association study on coronary artery disease in type 1 diabetes suggests beta-defensin 127 as a risk locus. Cardiovascular Research. 117(2). 600–612. 15 indexed citations

10.

Syreeni, Anna, et al.. (2020). Genome‐wide search for genes affecting the age at diagnosis of type 1 diabetes. Journal of Internal Medicine. 289(5). 662–674. 2 indexed citations

11.

Syreeni, Anna, Niina Sandholm, Jingjing Cao, et al.. (2019). Genetic Determinants of Glycated Hemoglobin in Type 1 Diabetes. Diabetes. 68(4). 858–867. 14 indexed citations

12.

Sandholm, Niina, Anmol Kumar, Kustaa Hietala, et al.. (2019). CACNB2 Is a Novel Susceptibility Gene for Diabetic Retinopathy in Type 1 Diabetes. Diabetes. 68(11). 2165–2174. 14 indexed citations

13.

Bernardi, Luciano, Daniel Gordin, Anna Syreeni, et al.. (2013). Effects of a Single Bout of Interval Hypoxia on Cardiorespiratory Control in Patients With Type 1 Diabetes. Diabetes. 62(12). 4220–4227. 13 indexed citations

14.

Ahlqvist, Emma, Carol Forsblom, Niina Sandholm, et al.. (2012). SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes. Diabetologia. 55(9). 2386–2393. 19 indexed citations

15.

Syreeni, Anna, Assam El‐Osta, Carol Forsblom, et al.. (2011). Genetic Examination of SETD7 and SUV39H1/H2 Methyltransferases and the Risk of Diabetes Complications in Patients With Type 1 Diabetes. Diabetes. 60(11). 3073–3080. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact